Characterization of the effects of immunomodulatory drug fingolimod (FTY720) on human T cell receptor signaling pathways
Crossref DOI link: https://doi.org/10.1038/s41598-018-29355-0
Published Online: 2018-07-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baer, Alan
Colon-Moran, Winston
Bhattarai, Nirjal
Text and Data Mining valid from 2018-07-19
Version of Record valid from 2018-07-19
Article History
Received: 23 March 2018
Accepted: 10 July 2018
First Online: 19 July 2018
Competing Interests
: The authors declare no competing interests.